Diffusion Tensor Imaging in Diagnosing and Evaluating Degenerative Cervical Myelopathy: A Systematic Review and Meta-Analysis Publisher



Mohammadi M¹ ; Roohollahi F^{2, 3} ; Farahbakhsh F⁴ ; Mohammadi A¹ ; Mortazavi Mamaghani E¹ ; Kankam SB^{5, 6} ; Moarrefdezfouli A⁴ ; Ghamari Khameneh A⁷ ; Mahmoudi MM⁸ ; Baghdasaryan D⁹ ; Martin AR¹⁰ ; Harrop J¹¹ ; Rahimimovaghar V^{4, 12, 13, 14, 15}
Source: Global Spine Journal Published:2025

Abstract

Study Design: Systematic review. Objective: Degenerative cervical myelopathy (DCM) is a common spinal cord disorder necessitating surgery. We aim to explore how effectively diffusion tensor imaging (DTI) can distinguish DCM from healthy individuals and assess the relationship between DTI metrics and symptom severity. Methods: We included studies with adult DCM patients who had not undergone decompressive surgery and implemented correlation analyses between DTI parameters and severity, or compared healthy controls and DCM patients. Results: 57 studies were included in our meta-analysis. At the maximal compression (MC) level, fractional anisotropy (FA) exhibited lower values in DCM patients, while apparent diffusion coefficient (ADC), mean diffusivity (MD), and radial diffusivity (RD) were notably higher in the DCM group. Moreover, our investigation into the diagnostic utility of DTI parameters disclosed high sensitivity, specificity, and area under the curve values for FA (.84,.80,.83 respectively) and ADC (.74,.84,.88 respectively). Additionally, we explored the correlation between DTI parameters and myelopathy severity, revealing a significant correlation of FA (.53, 95% CI:0.40 to.65) at MC level with JOA/mJOA scores. Conclusion: Current guidelines for DCM suggest decompressive surgery for both mild and severe cases. However, they lack clear recommendations on which mild DCM patients might benefit from conservative treatment vs immediate surgery. ADC’s role here could be pivotal, potentially differentiating between healthy individuals and DCM. While it may not correlate with symptom severity, it might predict surgical outcomes, making it a valuable imaging biomarker for clearer management decisions in mild DCM. © The Author(s) 2024.